Tyrosine Kinase Stocks List

Recent Signals

Date Stock Signal Type
2021-05-05 ANGN 20 DMA Resistance Bearish
2021-05-05 BPMC Stochastic Reached Oversold Weakness
2021-05-05 COGT Bollinger Band Squeeze Range Contraction
2021-05-05 COGT 50 DMA Resistance Bearish
2021-05-05 EXEL 20 DMA Resistance Bearish
2021-05-05 EXEL Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-05 EXEL Pocket Pivot Bullish Swing Setup
2021-05-05 EYPT Crossed Above 50 DMA Bullish
2021-05-05 EYPT Expansion Pivot Buy Setup Bullish Swing Setup
2021-05-05 KALA New 52 Week Closing Low Bearish
2021-05-05 KALA Stochastic Reached Oversold Weakness
2021-05-05 KALA Lower Bollinger Band Walk Weakness
2021-05-05 KALA New 52 Week Low Weakness
2021-05-05 KIN MACD Bearish Centerline Cross Bearish
2021-05-05 KIN MACD Bearish Signal Line Cross Bearish
2021-05-05 KIN 20 DMA Resistance Bearish
2021-05-05 KIN Fell Below 50 DMA Bearish
2021-05-05 KRON Shooting Star Candlestick Bearish
2021-05-05 KRON 50 DMA Resistance Bearish
2021-05-05 KRON Stochastic Sell Signal Bearish
2021-05-05 KRON Lizard Bearish Bearish Day Trade Setup
2021-05-05 NRIX MACD Bearish Centerline Cross Bearish
2021-05-05 NRIX Fell Below 20 DMA Bearish
2021-05-05 PBYI MACD Bearish Signal Line Cross Bearish
2021-05-05 PBYI 20 DMA Resistance Bearish
2021-05-05 PBYI Bollinger Band Squeeze Range Contraction
2021-05-05 RIGL NR7 Range Contraction
2021-05-05 RIGL Doji - Bullish? Reversal
2021-05-05 RIGL MACD Bearish Signal Line Cross Bearish
2021-05-05 RLAY Bollinger Band Squeeze Range Contraction
2021-05-05 RLAY Stochastic Reached Oversold Weakness
2021-05-05 RLAY New 52 Week Closing Low Bearish
2021-05-05 RLAY Spinning Top Other

Recent News for Tyrosine Kinase Stocks

Date Stock Title
May 5 RIGL Rigel Pharmaceuticals, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 5 EXEL Exelixis Q1 Earnings Preview
May 5 RIGL Rigel Pharmaceuticals EPS beats by $0.26, beats on revenue
May 5 RIGL Rigel Reports First Quarter 2021 Financial Results and Provides Business Update
May 5 EYPT EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q1 2021 Results - Earnings Call Transcript
May 5 KALA Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q1 2021 Results - Earnings Call Transcript
May 5 EYPT EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Misses Revenue Estimates
May 5 KALA Kala Pharmaceuticals (KALA) Reports Q1 Loss, Misses Revenue Estimates
May 5 EYPT EyePoint Pharmaceuticals EPS beats by $0.01, misses on revenue
May 5 KALA Kala Pharmaceuticals EPS misses by $0.01, misses on revenue
May 5 KALA Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 5 EYPT EyePoint Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent Corporate Developments
May 5 RLAY Relay Therapeutics to Participate in Fireside Chat at Bank of America 2021 Health Care Conference
May 5 RIGL Earnings Scheduled For May 5, 2021
May 4 EXEL Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma’s First-in-Class Humanized Antibody Program Against a Novel Oncology Target
May 3 BBIO BridgeBio Pharma Stock Forecast: A Long-Term Buy Or Sell
May 3 COGT Cogent Biosciences names new chief legal officer
May 3 KIN Kindred Biosciences to Announce First Quarter 2021 Financial Results
May 3 BBIO SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BridgeBio Pharma, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
May 3 COGT Cogent Biosciences Appoints Evan Kearns as Chief Legal Officer
Related Industries: Biotechnology Other